Free Trial
NASDAQ:THAR

Tharimmune (THAR) Stock Price, News & Analysis

Tharimmune logo
$1.63 -0.03 (-2.04%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Tharimmune Stock (NASDAQ:THAR)

Key Stats

Today's Range
$1.62
$1.68
50-Day Range
$1.29
$1.94
52-Week Range
$0.95
$6.39
Volume
10,013 shs
Average Volume
370,677 shs
Market Capitalization
$4.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.00
Consensus Rating
Strong Buy

Company Overview

Tharimmune Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
50th Percentile Overall Score

THAR MarketRank™: 

Tharimmune scored higher than 50% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tharimmune has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Tharimmune has received no research coverage in the past 90 days.

  • Read more about Tharimmune's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tharimmune is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tharimmune is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Tharimmune has a P/B Ratio of 2.38. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Tharimmune's valuation and earnings.
  • Percentage of Shares Shorted

    2.15% of the float of Tharimmune has been sold short.
  • Short Interest Ratio / Days to Cover

    Tharimmune has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tharimmune has recently increased by 107.14%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Tharimmune does not currently pay a dividend.

  • Dividend Growth

    Tharimmune does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.15% of the float of Tharimmune has been sold short.
  • Short Interest Ratio / Days to Cover

    Tharimmune has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tharimmune has recently increased by 107.14%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    2 people have searched for THAR on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Tharimmune to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Tharimmune insiders have bought more of their company's stock than they have sold. Specifically, they have bought $592,464.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    10.01% of the stock of Tharimmune is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 1.16% of the stock of Tharimmune is held by institutions.

  • Read more about Tharimmune's insider trading history.
Receive THAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter.

THAR Stock News Headlines

I warned you about Nvidia… now look what’s happening
Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.
Tharimmune CFO Don Kim Resigns
See More Headlines

THAR Stock Analysis - Frequently Asked Questions

Tharimmune's stock was trading at $2.03 at the beginning of 2025. Since then, THAR shares have decreased by 20.2% and is now trading at $1.62.

Tharimmune, Inc. (NASDAQ:THAR) issued its quarterly earnings data on Monday, May, 12th. The company reported ($0.99) earnings per share for the quarter, missing the consensus estimate of ($0.84) by $0.15.

Tharimmune's stock reverse split on the morning of Tuesday, May 28th 2024.The 1-15 reverse split was announced on Tuesday, May 28th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 28th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of THAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tharimmune investors own include Jiuzi (JZXN), Avenue Therapeutics (ATXI), Scinai Immunotherapeutics (SCNI), Adial Pharmaceuticals (ADIL), Sphere 3D (ANY), Blackboxstocks (BLBX).

Company Calendar

Last Earnings
5/12/2025
Today
7/22/2025
Next Earnings (Estimated)
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:THAR
Previous Symbol
NASDAQ:THAR
CIK
1861657
Fax
N/A
Employees
2
Year Founded
N/A

Price Target and Rating

High Price Target
$17.00
Low Price Target
$17.00
Potential Upside/Downside
+921.6%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($7.88)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.20 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-489.33%
Return on Assets
-264.34%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.67
Quick Ratio
0.67

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.68 per share
Price / Book
2.45

Miscellaneous

Outstanding Shares
2,661,000
Free Float
2,395,000
Market Cap
$4.43 million
Optionable
Not Optionable
Beta
1.21
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:THAR) was last updated on 7/22/2025 by MarketBeat.com Staff
From Our Partners